PolyPid Ltd. (PYPD) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Polypid Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.633 Greetings and welcome to the PolyPid second quarter 2026 00:00:04.633 -- 00:00:09.835 conference call. As a reminder, this call is recorded and I would now 00:00:09.835 -- 00:00:15.357 like to introduce your host for today's conference, Yuda Liebler from ARCS Investor 00:00:15.357 -- 00:00:19.758 Relations. Mr. Liebler, you may begin. 00:00:21.400 -- 00:00:26.822 Thank you, operator, and thank you all for joining PolyPid's second quarter 2026 earnings 00:00:26.822 -- 00:00:31.745 conference call. Joining me on the call today will be Dikla Czaczkes Akselbrad, Chief 00:00:31.745 -- 00:00:37.189 Executive Officer of PolyPid, Jonny Missulawin, PolyPid's Chief Financial Officer, 00:00:37.189 -- 00:00:41.733 and Ori Warshavsky, Chief Operating Officer, U.S., of PolyPid. 00:00:41.733 -- 00:00:46.336 Earlier today, PolyPid released its financial results for the three and six months ended 00:00:46.336 -- 00:00:51.360 June 30, 2026. A copy of the press release is available on the Investors section 00:00:51.360 -- 00:00:55.201 of the company's website at www.polypid.com. 00:00:55.978 -- 00:00:59.959 I'd like to remind you all that on this call, management will make forward-looking statements 00:00:59.959 -- 00:01:02.420 within the meaning of the federal securities laws. 00:01:02.420 -- 00:01:06.842 For example, management is making forward-looking statements when it's discussing the 00:01:06.842 -- 00:01:10.903 company's exclusive commercialization partnership with Azordi Pharmaceuticals for the 00:01:10.903 -- 00:01:14.904 United States and Canada. These forward-looking statements include the partnership's 00:01:14.904 -- 00:01:19.746 economic structure, including the potential milestone payments, tiered royalties, and 00:01:19.746 -- 00:01:...